GlassScriptPhysician profile
William Alfred Smith
NPI 1629230552
$2,008.15
in general payments reported to CMS, 2019-2025
29 companies · $326 in 2025
The $326 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $337 · 2020: $165 · 2021: $259 · 2022: $256 · 2023: $470 · 2024: $195 · 2025: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $991.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $990.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $360.73 | 2021-2024 | Axonics |
| Boston Scientific Corporation | $226.90 | 2019-2025 | Moses 550 D\F\L, Axonics, Lithovue |
| Janssen Biotech, INC. | $199.19 | 2019-2025 | Erleada |
| Astellas Pharma US INC | $194.95 | 2019-2023 | Myrbetriq |
| Abbvie INC. | $127.40 | 2020-2025 | |
| Angiodynamics, INC. | $106.98 | 2023 | Nanoknife, Biosentry Tract Sealant System |
| Endo Pharmaceuticals INC. | $87.81 | 2019-2022 | |
| Pfizer INC. | $81.14 | 2023-2025 | |
| Antares Pharma, INC. | $63.19 | 2019-2021 | |
| Amgen INC. | $51.56 | 2021-2023 | Xgeva |
| Dendreon Pharmaceuticals LLC | $42.59 | 2019-2023 | Provenge |
| Merck Sharp & Dohme LLC | $40.76 | 2020-2022 | |
| Caldera Medical, INC | $36.71 | 2021 | |
| Procept Biorobotics Corporation | $35.60 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Neotract INC. | $34.40 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accord Healthcare, INC. | $31.42 | 2022 | |
| Verity Pharmaceuticals INC. | $30.20 | 2024 | Trelstar |
| C. R. Bard, INC. & Subsidiaries | $28.30 | 2020 | |
| Sun Pharmaceutical Industries INC. | $27.24 | 2022 | |
| Laborie Medical Technologies Corp. | $27.18 | 2022 | |
| Davol INC. | $26.27 | 2020 | |
| Innovation Technologies INC | $23.71 | 2024 | Irrisept |
| Ethicon US, LLC | $22.07 | 2025 | Surgiflo Hemostatic Matrix |
| Blue Earth Diagnostics | $19.77 | 2021 | |
| Ambu INC. | $19.77 | 2025 | |
| Travere Therapeutics, INC. | $19.12 | 2019 | |
| Urogen Pharma, INC. | $16.28 | 2021 | |
| Levita Magnetics International Corp | $14.72 | 2019 | |
| Metuchen Pharmaceuticals | $12.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.